Stockreport

Immunome's Chief Scientist Trimmed His Stake. A Planned FDA Submission Tells You More [Globe and Mail, The (Toronto, Canada)]

Immunome, Inc.  (IMNM) 
PDF All shares sold were held directly; 3,000 shares remain held indirectly after the sale. Higgins has a post-sale direct holding of 22,000 shares. Jack Higgins, Chief [Read more]